News About: Pharm. Industry
Status of pharmaceutical industry
Status
1. Number of manufacturers
Class
All manufacturers1)(561)
KPMA member company2)(226)
GMP company2)(241)
Finished drugs
212
178
205
Bulk drugs
235
61
57
Quasi...
Pharmaceutical sales promotion no longer trended through conference sponsorship.
On the way back from the visit to the United States following the same to Japan recently, the KPMA Survey Team acknowledged that the conference sponsorship for physicians by pharmaceutical industries was showing a res...
BMS Korea to expand more business tie-up with local partners.
While most of foreign multinational drug corporations recalled their product licences from the domestic business partners, BMS Korea is rather expanding more business tie-ups with domestic partners.
BMS Korea made ...
Sales of foreign-invested pharmaceutical firmshit snag
After the implementation of a new system of separating drug dispensing from medical practice (SDP function), the majority of foreign-invested pharmaceutical firms have sharply boosted their market share in the domesti...
New KRPIA chairman stresses efficient cost of drugs
The Korea Research-based Pharmaceutical Industry Association (KRPIA) plans to rectify the public's negative reactions on high-priced drugs, while highlighting the notion that foreign-invested pharmaceutical firms in K...
Silkworm-containing health foods market contested by three domestic pharmaceutical firms
Business sources say that the domestic silkworm-containing health foods market has emerged as an arena of tripartite competition - Keuhwha Pharm's Nuegra, Dongsung Pharm's Power Nuesaengryuk, and Union Korea's Anigra ...
Indian companies likely to supply Gleevec.
The Chronic Leukemia Patient Association and the Joint Committee for Gleevec Issue are trying to produce Gleevec in association with foreign pharmaceutical company.
According to the Joint Committee, the represent...
Foreign-invested firms calling for withdrawal of reference pricing system
Foreign-invested pharmaceutical firms have called for the government to cautiously introduce the reference pricing system (RPS), which has been promoted by the government in a bid to ensure better finance stability in...
Big changes are foreseeable in hormone therapies
Market analysts say the domestic hormone therapies market is likely to shrink due to the recent announcement of the U.S. National Institute of Health that combined female hormone preparations is associated with a high...
Five-day workweek system expected to bring about much changes in drug distribution
Amid the growing expansion of the five-day workweek in all industry sectors, many domestic pharmaceutical firms plan to introduce the five-day workweek, heralding great changes in the domestic drug distribution.
Bu...
